| Literature DB >> 27508874 |
David W Frederick1, Emanuele Loro2, Ling Liu3, Antonio Davila1, Karthikeyani Chellappa1, Ian M Silverman4, William J Quinn1, Sager J Gosai4, Elisia D Tichy5, James G Davis1, Foteini Mourkioti5, Brian D Gregory4, Ryan W Dellinger6, Philip Redpath7, Marie E Migaud7, Eiko Nakamaru-Ogiso8, Joshua D Rabinowitz3, Tejvir S Khurana2, Joseph A Baur9.
Abstract
NAD is an obligate co-factor for the catabolism of metabolic fuels in all cell types. However, the availability of NAD in several tissues can become limited during genotoxic stress and the course of natural aging. The point at which NAD restriction imposes functional limitations on tissue physiology remains unknown. We examined this question in murine skeletal muscle by specifically depleting Nampt, an essential enzyme in the NAD salvage pathway. Knockout mice exhibited a dramatic 85% decline in intramuscular NAD content, accompanied by fiber degeneration and progressive loss of both muscle strength and treadmill endurance. Administration of the NAD precursor nicotinamide riboside rapidly ameliorated functional deficits and restored muscle mass despite having only a modest effect on the intramuscular NAD pool. Additionally, lifelong overexpression of Nampt preserved muscle NAD levels and exercise capacity in aged mice, supporting a critical role for tissue-autonomous NAD homeostasis in maintaining muscle mass and function.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27508874 PMCID: PMC4985182 DOI: 10.1016/j.cmet.2016.07.005
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287